I'm pretty sure everyone knows this, the first thing a lot of investors do, after Thanksgiving is to ask their brokers where they stand on Capital Gains. Then they lay out a plan for how they deal with that, i.e. sell losers to offset gains, etc. Then after 30 days you get to keep the tax loss and can buy back in.
The second thing that traders with deep pockets do (assuming they have a family) is to focus on the Holidays. I doubt that the people working on this are focused on this in December. I could be wrong, but in 30+ years, I've had very few "run" in December.
So set some alerts on your accounts so you'll know if volumes pick up and enjoy the company of friends and family. Your phone will let you know if something is happening. And don't expect it in the week after New Year either. But January can be the time of year when traders, who have been out of the stock for 30 days, can buy back in while still keeping their losses. Couple that with news and it's going past a couple of pennies, imo.
GL and Happy Holidays to All!
It's the only way to play.
This has time.
Does not look like it. I think I’ll keep some cash handy in case it goes below 005 again
For any possible new investors doing weekend DD and a reminder to current shareholders, here's what is on the horizon for NHYF.
Natural Harmony Foods Inc. Announces New Strategic Direction and Sets the Stage for a Revolution In Healthcare and Wellness
September 19, 2023 at 10:03 AM EDT
NEW YORK, NY / ACCESSWIRE / September 19, 2023 / Publicly-held Natural Harmony Foods, Inc. (OTC PINK:NHYF) (the Company) announces that following the change of control to Mr. Claudio Solitario, announced recently, the Company is now on a transformative path, signaling a compelling strategic direction. The Company's transition under Claudio's leadership signifies a dynamic shift towards innovation and growth, underpinned by his extensive knowledge and experience in medical technology and intellectual property development and commercialization. Mr. Claudio Solitario The Power of Artificial Intelligence Solutions in Healthcare Central to NHYF's transformation is its commitment to harness the power of Artificial Intelligence (AI) in healthcare. AI-driven medical technology is set to revolutionize the field, promising faster, more accurate diagnoses; personalized treatment plans, and improved patient outcomes. AI's potential to transform the medical field is undeniable, offering promise of more efficient and effective healthcare for all. The Company will be at the forefront of this exciting advancement in medical technology focusing on the development of AI-powered screening methods and to this end, is forming strategic partnerships in an effort to co-develop the following: * Life-Saving Innovation: AI-based intellectual property for the fast and early identification of life threatening pulmonary embolisms using CAT scan detection software. A pulmonary embolism is a medical emergency; it may be fatal causing death. Pulmonary embolism affects around 900,000 people in the U.S. every year^1. The AI-powered technology aims to improve the radiologic processing time and reading performance during emergency evaluations. * Facial Analysis to objectively screen for PTSD: AI-based facial analysis technology to objectively screen for post-traumatic stress disorder. The technology will analyze and interpret facial data, the result of which will be seen immediately by the user - with an option of sending it to their medical practitioner. This innovative approach will empower individuals and their healthcare providers to proactively manage mental health. The incidence of mental illness in the USA is well known; and the cost is estimated at $300Billion annually^2. A quick and objective assessment of PTSD is required by patients and healthcare professionals alike. * Evolution in Evaluation and Treatment of Pain Management: A breakthrough new AI program (Chatbot) to simulate conversation with individuals suffering from chronic pain. The program will be designed to immediately address the pain sufferer's acute and chronic pain and provide viable options to consider as they search for a medical personnel who has the appropriate expertise. It will also create a written dialogue that can be reviewed by medical practitioners and may become an integral part of the pain sufferer's comprehensive pain management plan. This breakthrough AI-based technology, under the guidance of Dr. Robert Lawrence, a retired Neurologist with PhDs in Nuclear Physics and Biomedical Engineering, along with MS Degrees in Computer Science and Pharmacology, will be a game-changer for the over 51 million Americans (over 20% of the adult population^3) affected by chronic pain. AI's capacity to process vast volumes of data positions it as a pivotal tool in the aid to diagnosis across diverse medical domains. By leveraging machine learning algorithms, AI can analyze vast amounts of medical data, from patient records to medical images and by identifying patterns and insights that may escape human detection. This capability can lead to earlier and more accurate diagnoses, personalized treatment plans and improved patient outcomes. Importantly, AI-powered technologies can also enhance patient engagement, provide 24/7 support and help individuals manage their health proactively. Innovative Nutritional Wellness Solutions for Early Revenue Opportunity NHYF's vision extends beyond AI, encompassing innovative nutraceutical solutions. The company is poised to launch an anti-anxiety product - the first of its nutritional supplements that can be added to medical protocols for the long-term management of anxiety. The formula was scientifically designed as an active dietary supplement to nutritionally support the body's inherent abilities to positively respond to stressful conditions. It will address the needs of the great many people who are searching for natural supplements that may help address symptoms associated with their anxiety. David Anderson MD, a highly respected U.S. medical school-associated research physician will ensure all claims and presentations are maximized whilst complying with Regulatory Agency Guidelines. The market for nutraceuticals in the USA has been experiencing robust growth, driven by increasing consumer awareness of the link between diet, health, and wellness. With a growing emphasis on preventive healthcare, the demand for dietary supplements and functional foods that offer potential health benefits beyond basic nutrition continues to expand, creating a dynamic landscape for the Company's nutraceutical businesses to flourish. Change of OTC Market Company Status The transition of the Company's business to the development of medical technology and the commercialization of wellness products will require a higher level of corporate governance and transparency. To this end the Company is working towards a change of status from Pink to OTCQB. Speaking on behalf of the Company, newly appointed CEO, Mr. Claudio Solitario said: " We are excited to embark on this transformative journey. AI is fast becoming an important tool in the quest for faster and more accurate diagnoses. Our mission is to leverage AI to enhance health outcomes and reduce healthcare costs. We also look forward to launching our pioneering anti-anxiety formula, the first of our nutraceutical products. The market demand for nutraceuticals is significant and growing, representing an early revenue opportunity for the Company. The path ahead is exciting and we look forward to keeping shareholders abreast of progress in the coming weeks and months". ^1 https://www.lung.org/lung-health-diseases/l ung-disease-lookup/pulmonary-embolism/learn-about-pulmonary-embolism ^2 https://www.nami.org/Press-Media/In-The-New s/2021/2020-devastated-US-mental-health-%E2%80%94-healing-must-be-a-priority ^3 https://www.cdc.gov/mmwr/volumes/72/wr/mm72 15a1.htm#contribAff For media and Investor Relations inquiries, please contact: firstname.lastname@example.org The official website at www.nhyf.net About Natural Harmony Foods Inc. Natural Harmony Foods Inc. (NHYF) aims to enhance patient outcomes and reduce healthcare costs by developing cutting-edge AI-powered methods to aid in the diagnosis of medical conditions. These methods enable early, accurate screening, contributing to quicker and more effective treatment. NHYF focuses on developing AI-based screening techniques for medical conditions, capitalizing on the growing role of AI in clinical practice. Additionally, NHYF acknowledges the thriving nutraceutical market's potential and plans to enter it for early revenue, benefiting from the growing emphasis on natural approaches and the demand for dietary supplements that offer potential health benefits beyond basic nutrition. The demand for nutraceuticals continues to expand, creating a dynamic landscape for NHYF's nutraceutical businesses to flourish. Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "will" and similar references to future periods. Examples of forward-looking statements in this press include, among others, statements about our renegotiated settlement agreement. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our limited operating history; our dependence on third parties for many aspects of our business; general market and economic conditions; technical factors; the availability of outside capital; our receipt of revenues; legislative developments; changes in our expenditures and other uses of cash; our ability to find, recruit and retain personnel in sufficient numbers to support our growth; our ability to manage growth; and general market, economic and business conditions. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. SOURCE: Natural Harmony Foods, Inc. via PRISM Mediawire, LLC View source version on accesswire.com: https://www.accesswire.com/785316/natural-harmony-foods-inc-announces-new-st rategic-direction-and-sets-the-stage-for-a-revolution-in-healthcare-and-wellness
With a 280m O/S with insiders holding a good 80m, I'm hoping this breaks over a dime on minimal news.
The price is fun potential today.
I'm blown away it's not tanked in half with so many shares floating out there.
It should break to .01 - .03 and beyond with any kind of volume
Big runner in Q1 2024 im feeling. You can tell shares are getting locked up tight day by day.
so strange... also feel like we'll run big sooner than later...
Right? Such an odd play but for that reason it feels like a unicorn
Crazy how there is no vol today
Yep. Up 42% today on light volume. Strong hands here.
ask hits,,, not going to take much. $NHYF
Ben scored big today in ECPL.
Maybe he has some working capital to get the job done here.
I'd love to have two synergy shells take off in the same week.
Let's goooooo so close to big money no wammys
And we still have this block of restricted shares to be canceled.
After that, I think the stock goes to the next level.
Time to add is now till we get word from the courts. God! how they can drag their feet.
So as a accumulator, I'm pumped.
$NHYF - I had someone ask me my thoughts on the timing... Next week is the Turkey event, no one is paying attention.
The week after (Thanksgiving), for those with shekels is seeing the fam off at the airport and settling back into a routine for a couple of days (You can do that when you have millions)
The following week, you sit down with your accountant (CPA) and your broker/investment group and you try to see if there are moves you should make to reduce your Capital Gains (taxes). You have until Dec 31st to make those moves. (transaction needs to close). You need to have your agents working on this through the week before Christmas and up until New Year)
The next week (one before Christmas) can be more of the same and then you get ready for the family event (Christmas). And when that and New Year's is over they slowly re-enter the markets, 2nd half of January to early February. If you had tens of millions, you would do the same.
January sounds about right...probably the 2nd half or early February, imo
I got a few on the bid today but was out running errands so I missed some opportunities. But there is probably some time between now and January to buy some more. GL2U and Wish everyone a Happy Holiday!
Looks like we are in for a GOLDEN TIME. Things are taking longer but this seems to be much bigger than many thought. I don't mind waiting into 1st Quarter 2024 for our big PAYDAY $$$
Diamond hands here
I was also very happy with my scoop today.
Take a look at Belisarian Holdings, the newest custodians on the block. They have moved very swiftly on their tickers. Take a look at ZHUD. It’s a beautiful shell for a reverse merger. These guys move very fast. I have been very impressed.
Yes. It used to be one hell of a gravy train buying up shells from these types of krews and pray. I used to hold no less than 30 shells getting a good 200-800% a few times a month. Biden has killed motivations and confidence in going public.
Ben and I had a very mutual and open line of communications. Not much to talk about now.
Synergy is the only one left in this space.
Lazar, AlphaRidge, Goff, and others haven't pulled off a R/M in years.
There are 2 shares of the Series B stock, each share entitles the owner to 4.99% of the O/S - Berry owns one and Solitario owns one. Berry's is listed as an exchange for his services as a Director, and Solitario is listing his as "Voting Control".
Then there is a 200-share block that is owned by Solitario and they provide the owner a guaranteed 60% of the vote on any issue. That's your poison pill.
This information can be found on Page 4 of the following document (11/15 10-Q) https://www.otcmarkets.com/otcapi/company/financial-report/386610/content
I do think that Berry isn't in this to dump his shares at these levels, remember this is what his firm does. They find distressed companies, turn them around, and make them whole. Then they profit from a much improved share price. We shall see as it moves forward.
Those Bs will be pure gold if they build this up and find a buyer.
That's all those are good for. They will never convert. They are a control poision pill.
Why even have em if they don't have big plans for this?
3-5 year plan. Many will get out and back in over the years.
I want to see 400-600% run from down here and stay there.
Then it's money in the bank to me.
Score a 1,000%, I'll get my original out and really be in the drivers seat.
$NHYF - This is what Berry is entitled to. 2 shares of the 2023 Series B shares were issued, one to Berry and one to Solitario. This is what they convert to:
Preferred B: 1 Preferred converts to 4.99% of the outstanding common shares at the time of conversion.
KEY WORDS, at the time of conversion. I'm guessing these are not short-term holders so they'll wait on converting these until there are more shares in the O/S (remember 100 mil reduction coming) but as they grow they can use the shares for funding for new opportunities and at the risk of being labeled "a Student of the Obvious". It won't be down here. imo
Agreed actually looks like they have lots coming. Todays news spelled it out pretty much for those who looked deeply into it
Sorry man. Got my tickers confused this morning. I had TK&VR in my mind going above $2.50
I have 1/10 of my hold set to sell @ .06
I'll ride the rest free for a few years.
I'll hold so long as Ben holds. I'm not sure the amount he deferred taking shares instead of cash. $50k-$150k? I'd assume he wants way more than that.
@.06, Ben is well funded to the tune of $1.4m on his 22.5m shares. And I'm sure he would make a block deal with NHYF to get a lump sum and retire his shares back into treasury.
I'm still adding when I can.
Where is this thing going?
PPS in 6 months to a year?
I like what I'm seeing here. Alot.
The funds will be used to launch the first of the Company's nutraceutical products; the acquisition and development (subject to due diligence) of AI-based intellectual property; and general working capital, including up-listing the Company to OTCQB status as quickly as possible.
Mr. Randy Rivera, Director of Global Corporate Finance, said:
"The investment in NHYF is a logical step in GCF's strategy to invest in companies at the forefront of AI-powered medical technology. Companies with unique strategic investments in the AI medtech space have the potential to develop significant value over the next two to five years and we look forward to a long and productive association with NHYF".
Mr. Claudio Solitario, CEO of Natural Harmony Foods Inc. adds:
"We are delighted to be partnering with Global Corporate Finance Inc. and are very grateful for their financial support. The facility will provide the capital required to execute our growth plans and build shareholder value. Our collaboration with GCF is a testament to our shared vision for innovation and growth. The capital will serve as a dynamic catalyst to propel our strategic initiatives forward. We too look forward to a long and productive working relationship with GCF".
For media and Investor Relations inquiries, please contact: email@example.com
The official website at www.nhyf.net
It's all in how they sold the story to the funding arm.
These guys are not going to want shares just to dump and watch this go sub penny just to try and dump a few 100k shares. This will tank more than 9% in a few 1,000 shares.
The funding guys are investors. Partners in this story now. They will exit when the time is right.
There is no liquidity in the stock to dump. Anyone dumping now will kill it. They know this too.
Hell I know a handful of money guys that will fund any pump and dump ticker you show them. They will be happy to dump Billions and R/S till the SEC stops them.
You have something special here. Keep an eye on the members and paid subscribers
And trust me, the funding guys want as much as they can out of this.
Or they want shares to take a loss, drive it in the box, then buy up the free float? Doubt it.
$2.50 eoukd be insane